Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: The roles of surgery and chemotherapy

被引:71
作者
von Gruenigen, Vivian E.
Frasure, Heidi E.
Jenison, Eric L.
Hopkins, Michael P.
Gil, Karen M.
机构
[1] Univ MacDonald Womens Hosp, Div Gynecol Oncol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA
[3] Northeastern Ohio Univ Coll Med & Pharm, Dept Obstet & Gynecol, Rootstown, OH 44272 USA
[4] Akron Gen Med Ctr, Dept Obstet & Gynecol, Akron, OH 44307 USA
[5] Univ Hosp Cleveland, Dept Obstet & Gynecol, Div Gynecol Oncol, Cleveland, OH 44106 USA
关键词
chemotherapy; complementary and alternative medicine; gynecologic oncology; ovarian cancer; quality of life; surgery;
D O I
10.1016/j.ygyno.2006.01.059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. To prospectively evaluate quality of life (QoL), use of complementary and alternative medicine (CAM), and diet/exercise changes in ovarian cancer patients during the first 6 months following diagnosis. Methods. Patients with newly diagnosed ovarian cancer were enrolled pre- or post-operatively and surveyed at 3 and 6 months. The Functional Assessment of Cancer Therapy (FACT-G), Medical Outcomes Survey (SF-36), and CAM/diet/exercise questionnaires were used. Independent samples t test and repeated measures ANOVA were used. Results. Forty-two patients underwent surgical debulking and staging prior to chemotherapy. Patients completing the initial surveys post-operatively had significantly lower physical FACT-G and SF-36 physical scores compared to patients completing the surveys pre-operatively. In patients completing the baseline survey pre-operatively, there was a decrease in physical scores at 3 months (after surgery and during chemotherapy). There was no change observed at 3 months relative to baseline when patients completed the baseline survey post-operatively. Increases in physical and functional well-being were seen at 6 months relative to 3 months. There were no changes in emotional or social scores over time. CAM use increased over time; main reasons were to improve QoL and relieve symptoms. Alterations in diet and exercise were not seen. Conclusions. These data highlight the need to conduct assessments before and after surgery to identify effects due to surgery and/or chemotherapy. Patients may be using CAM during chemotherapy to deal with symptoms and compensate for decreased QoL. Intervention trials should be implemented to increase QoL following surgery and during adjuvant chemotherapy. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 38 条
  • [1] Reliability and validity of the functional assessment of cancer therapy-ovarian
    Basen-Engquist, K
    Bodurka-Bevers, D
    Fitzgerad, MA
    Webster, K
    Cella, D
    Hu, SH
    Gershenson, DM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1809 - 1817
  • [2] Quality of life in ovarian cancer patients: Comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study
    Bezjak, A
    Tu, DS
    Bacon, M
    Osoba, D
    Zee, B
    Stuart, G
    Roy, JA
    Piccart, M
    Eisenhauer, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4595 - 4603
  • [3] Do adults change their lifestyle behaviors after a cancer diagnosis?
    Blanchard, CM
    Denniston, MM
    Baker, F
    Ainsworth, SR
    Courneya, KS
    Hann, DM
    [J]. AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2003, 27 (03) : 246 - 256
  • [4] Depression, anxiety, and quality of life in patients with epithelial ovarian cancer
    Bodurka-Bevers, D
    Basen-Engquist, K
    Carmack, CL
    Fitzgerald, MA
    Wolf, JK
    de Moor, C
    Gershenson, DM
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 78 (03) : 302 - 308
  • [5] Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial
    Butler, L
    Bacon, M
    Carey, M
    Zee, B
    Tu, DS
    Bezjak, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2461 - 2468
  • [6] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579
  • [7] A controlled trial of inpatient and outpatient geriatric evaluation and management
    Cohen, HJ
    Feussner, JR
    Weinberger, M
    Carnes, M
    Hamdy, RC
    Hsieh, F
    Phibbs, C
    Lavori, P
    Courtney, D
    Lyles, KW
    May, C
    McMurtry, C
    Pennypacker, L
    Smith, DM
    Ainslie, N
    Hornick, T
    Brodkin, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) : 905 - 912
  • [8] Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy
    Demark-Wahnefried, W
    Peterson, BL
    Winer, EP
    Marks, L
    Aziz, N
    Marcom, PK
    Blackwell, K
    Rimer, BK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) : 2381 - 2389
  • [9] Complementary and alternative medicine use among women with breast cancer
    DiGianni, LM
    Garber, JE
    Winer, EP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 34S - 38S
  • [10] DY GK, 2004, J CLIN ONCOL, V22, P4758